The Biggest Mid-Cap Catalysts In 2025 – And What Happens Next

 
• By Andrew McConaghie and Edwin Elmhirst
  
Snakes and Ladders
Some companies have been able to sustain their share prices rises but others have found it akin to snakes and ladders. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Start-Ups & SMEs

More from Business